Press Releases

ATLANTA, Aug. 12, 2019 /PRNewswire/ -- Surterra Wellness (Surterra), one of the fastest growing health and wellness companies in the United States (U.S.), today announced the expansion of its leadership team with the appointment of Stevens J. Sainte-Rose as Chief Human Resources Officer (CHRO) and as a member of it

QUEBEC CITY and MYRTLE BEACH, SC, Aug. 12, 2019 /PRNewswire/ - TSO3 Inc. (TSX: TOS) ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, reports financial results for the second quarter ended June 30, 2019. 2019 S

All amounts in this press release are in Canadian dollars unless otherwise specified. QUÉBEC CITY and MYRTLE BEACH, SC, Aug. 12, 2019 /PRNewswire/ - TSO3 Inc. ("TSO3" or the "Company") (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announc

BOSTON, Aug. 12, 2019 /PRNewswire/ -- 908 Devices, a pioneer of analytical devices for chemical and biomolecular analysis, today announced the launch of their new bioprocess analyzer,

SAN JOSE, Calif., Aug. 12, 2019 /PRNewswire/ -- ForteBio, the Biologics Business Unit of Molecular Devices, announced today at the Bioprocessing Summit in

WEST LAFAYETTE, Ind., Aug. 12, 2019 /PRNewswire/ -- On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-targeted imaging agents to improve cancer surgery, today announced that Christopher Barys has joined the company as Chief Executive Officer and will join the board of directors. Prior to joi

DALLAS, Aug. 12, 2019 /PRNewswire/ -- Essilor of America and actress Marsai Martin are raising awareness about the urgent need for children across the nation to receive total vision care this back to school season – care which includes high-quality, comprehensive eye exams from eyecare professionals who offer advanced lens technology that keep pace with the changi

ALPHARETTA, Ga., Aug. 12, 2019 /PRNewswire/ -- Holon Solutions, healthcare's leading data liberator, announced today it has been awarded its second U.S. Patent (No. 15/796,397) this yea

NASDAQ: CORV   TSX: CORV VANCOUVER, Aug. 12, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that an abstract highlighting the results of the SPECTRUM study evaluating Brinavess® (vernakalant hydrochloride, IV), the

BOTHELL, Wash., Aug. 12, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and suppl